by rss feed | Nov 11, 2026 | News Feeds
Publishing in the Journal of Hazardous Materials Advances, researchers from Kyushu University used zebrafish embryos to study the health effects of the PFAS called PFBS (Perfluorobutanesulfonic acid), a substitute PFAS thought to be safer than traditional compounds....
by rss feed | Nov 11, 2026 | News Feeds
The Vanderbilt Liver Transplant team recently performed three liver transplants in 12 hours, a remarkable feat that spotlights the capabilities of the Vanderbilt Transplant Center, the busiest in the nation. Read Original...
by rss feed | Nov 11, 2026 | News Feeds
For years, older patients with acute myeloid leukemia-an aggressive cancer of the blood and bone marrow-have needed clinic injections five to seven days a month, plus a daily oral pill. For these older patients, that clinic schedule can be quite demanding. Read...
by rss feed | Nov 11, 2026 | News Feeds
In a phase I clinical trial funded by the National Institutes of Health and the Maryland Stem Cell Research Fund, Johns Hopkins Medicine researchers say they have partially transformed ordinary human skin cells into volar skin - the durable skin found exclusively on...
by rss feed | Nov 11, 2026 | News Feeds
Deaf patients get a raw deal in NHS hospitals, suggests an illustrative case history of a deaf person's experience as an inpatient, published in the online journal BMJ Case Reports. Read Original...
by rss feed | Nov 11, 2026 | News Feeds
Over the past two years, a Children's Hospital Los Angeles team has treated 10 children with thalamic responsive neurostimulation (RNS), a groundbreaking therapy for generalized epilepsy as well as Lennox Gastaut syndrome. Read Original...
